Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical Trial to Evaluate the Safety and Effectiveness of Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions

NCT01305356 is registered in ClinicalTrials.gov with BioMimetic Therapeutics as lead sponsor.

NCT NCT01305356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01305356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical Trial to Evaluate the Safety and Effectiveness of Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions
Lead sponsor
BioMimetic Therapeutics
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2011
Completion date
April 30, 2014
Enrollment
299 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, congenital deformity, degenerative joint disease, osteoarthritis, rheumatoid arthritis